Artivion AORT Deferred preservation costs
Deferred preservation costs at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept aort:DeferredPreservationCosts.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's deferred preservation costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's deferred preservation costs?
- Artivion (AORT) reported deferred preservation costs of $53.41M in Q1 2026.
- How has Artivion's deferred preservation costs changed year-over-year?
- Artivion's deferred preservation costs increased by 2.0% year-over-year, from $52.38M to $53.41M.
- What is the long-term trend for Artivion's deferred preservation costs?
- Over 5 years (2020 to 2025), Artivion's deferred preservation costs has grown at a 8.3% compound annual growth rate (CAGR), from $36.55M to $54.53M.
- What does deferred preservation costs mean?
- These are capitalized costs associated with the preservation, storage, or maintenance of biological or medical inventory that will be recognized as an expense in future periods. This metric reflects the investment required to maintain the viability and quality of specialized medical products before they are sold. It is a critical component for understanding the cost structure and inventory management efficiency of companies dealing with sensitive biological materials.